1887
  1. Home
  2. Eurosurveillance
  3. Volume 21, Issue 16, 21/Apr/2016
  4. Article
Editorial Open Access
Like 0
Download
Preview this article:
Preview Magnify
Zoom in
Zoomout

Importance of timely monitoring of seasonal influenza vaccine effectiveness, Page 1 of 1

| /docserver/preview/fulltext/eurosurveillance/21/16/eurosurv-21-30209-1-1.gif

There is no abstract available for this article.
Use the preview function to the left.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2016.21.16.30209
2016-04-21
2020-01-18
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2016.21.16.30209
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/21/16/eurosurv-21-30209-1.html?itemId=/content/10.2807/1560-7917.ES.2016.21.16.30209&mimeType=html&fmt=ahah

References

  1. Mereckiene J, Cotter S, O’Flanagan D, VENICE III Consortium. National seasonal influenza vaccination survey for 2012-13 influenza season in EU/EEA (provisional data). Available from: http://venice.cineca.org/VENICE_Seasonal_Influenza_2012-13_v10.pdf
  2. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill. 2013;18(5):20390.
  3. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine. 2007;25(15):2842-51. Epub 2006 Oct 16.
  4. World Health Organization (WHO) Recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season. Geneva: WHO; Feb 2016. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/201602_recommendation.pdf?ua=1
  5. European Medicines Agency (EMA). Risk-management plans. London: EMA. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000360.jsp
  6. Leung VK, Cowling BJ, Feng S, Sullivan SG. Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review. Euro Surveill. 2016;21(16):pii=30202.  https://doi.org/10.2807/1560-7917.ES.2016.21.16.30202 
  7. Kissling E, Nunes B, Robertson C, Valenciano M, Reuss A, Larrauri A, et al. I-MOVE multicentre case–control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? . Euro Surveill. 2016;21(16):pii=30201.  https://doi.org/10.2807/1560-7917.ES.2016.21.16.30201 
  8. Cuesta JG, Aavitsland P, Englund H, Gudlaugsson Ó, Hauge SH, Lyytikäinen O, et al. Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience. Euro Surveill. 2016;21(16):pii=30208.  https://doi.org/10.2807/1560-7917.ES.2016.21.16.30208 
  9. Rainwater-Lovett K, Chun K, Lessler J. Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities: a systematic review Influenza Other Respir Viruses. 2014 Jan;8(1):74-82. doi:  https://doi.org/10.1111/irv.12203 . Epub 2013 Nov 7. Review. PMID: 24373292
  10. Torner N, Soldevila N, Garcia JJ, Launes C, Godoy P, Castilla J, et al. Effectiveness of non-pharmaceutical measures in preventing pediatric influenza: a case-control study. BMC Public Health. 2015;15:543.  https://doi.org/10.1186/s12889-015-1890-3 
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error